SF 131 Minnesota Senate · 2021-2022 Regular Session

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2021 Last action Mar 28, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
1
Jan 14, 2021
Committee
Referred to Health and Human Services Finance and Policy
upper
Jan 14, 2021
Introduced
Introduction and first reading
upper
1 primary · 1 co-sponsor

Sponsors